相关实验视频
Updated: Jan 7, 2026

07:36
Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
15.9K
血管生成中的血小板和肺前体细胞在慢性间歇性缺氧下回归
Ayşe Demirci Şahin1, Emel Güneş2, Göktuğ Ömercioğlu2
1Department of Physiology, Ankara University Faculty of Medicine, Ankara, Turkey. aysedemirc@yahoo.com.
Scientific reports
|December 9, 2025
概括
慢性间歇性缺氧 (CIH) 改变了血小板功能,减少了像SDF-1这样的关键血管性因素. 这会损害到受伤的肺部的内皮原生细胞 (EPC),阻碍血管的修复.
科学领域:
- 生理学 生理学 生理学
- 血管生物学 血管生物学
- 缺氧研究 缺氧研究
背景情况:
- 血小板对于组织修复至关重要,释放血管生成因子,如刺激内皮细胞原始细胞 (EPCs) 的树皮细胞衍生因子-1 (SDF-1).
- 已知慢性间歇性缺氧 (CIH) 影响血小板功能,但其对血小板衍生的血管性因素及其在急性肺损伤 (ALI) 中EPC招募的确切影响尚不清楚.
研究的目的:
- 研究CIH对血小板内亲血管原和抗血管原分子的特征的影响.
- 确定这些改变的血小板因子在ALI期间EPC指向肺部的作用.
- 阐明一个潜在的机制,通过CIH损害损伤肺部的血管修复.
主要方法:
- 大鼠接受CIH (每天6小时42天,模拟3000米高度) 和/或ALI.
- 测量了VEGF,SDF-1,PDGF,内静止素,血素-1 和PAI-1 的血小板度.
- 用VEGFR2和CD133.3的免疫光检测来评估EPC对肺的定位.
主要成果:
- CIH + ALI组的血小板数量增加,但每个血小板的SDF-1,VEGF,PDGF,PAI-1,内静止素和血栓松丁-1度显著降低.
- 在ALI组中观察到EPC定位,但在CIH和CIH + ALI组中没有.
- 在CIH + ALI组中,血小板衍生的SDF-1水平特别降低.
结论:
- CIH重编程血小板血管新生载荷,导致SDF-1的减少和其他血管新生因素的稀释.
- 在暴露于CIH的老鼠中观察到的EPC招募的缺乏表明血管修复机制受损.
- 由于CIH导致的血小板衍生的SDF-1降低可能代表一种新的途径,有助于ALI中血管修复受损.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Structure and Function of Platelets
2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Formation of the Platelet Plug
8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Pulmonary Hypertension: Classification and Pathogenesis
533
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
533

